𝛼SK or Search

ENTITY

BioVie (BIVI US)

2

Analysis

Health Care • United States

BioVie Inc. is a clinical stage biotechnology company engaged in the discovery, development and commercialization of therapies targeting life-threatening complications of liver cirrhosis. The Company's initial disease target is ascites a condition impacting people globally. BioVie is based out of the United States.

more

Refresh

Exchange Announcement • 15 Aug 2026 05:23

S-1/A | IPO Registration (Amendment)

Exchange Announcement • 12 Aug 2026 08:00

Annual Report (Form 10-K | Period ending 2026-06-30)

Exchange Announcement • 06 Aug 2026 19:41

S-1/A | IPO Registration (Amendment)

Exchange Announcement • 06 Aug 2026 19:35

Current Report (Form 8-K | Period ending 2026-08-06)

Exchange Announcement • 01 Aug 2026 05:29

S-1/A | IPO Registration (Amendment)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5

x